DexCom Statistics

Total Valuation

DexCom has a market cap or net worth of BRL 117.94 billion. The enterprise value is 114.94 billion.

Market Cap	117.94B
Enterprise Value	114.94B

Important Dates

The next confirmed earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.75%
Shares Change (QoQ)	-2.09%
Owned by Insiders (%)	0.37%
Owned by Institutions (%)	97.10%
Float	383.95M

Valuation Ratios

The trailing PE ratio is 25.60 and the forward PE ratio is 24.17.

PE Ratio	25.60
Forward PE	24.17
PS Ratio	4.59
PB Ratio	7.80
P/TBV Ratio	8.08
P/FCF Ratio	19.88
P/OCF Ratio	14.86
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.27, with an EV/FCF ratio of 19.37.

EV / Earnings	24.95
EV / Sales	4.95
EV / EBITDA	19.27
EV / EBIT	25.33
EV / FCF	19.37

Financial Position

The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.51.

Current Ratio	1.88
Quick Ratio	1.53
Debt / Equity	0.51
Debt / EBITDA	1.17
Debt / FCF	1.30
Interest Coverage	49.83

Financial Efficiency

Return on equity (ROE) is 34.50% and return on invested capital (ROIC) is 33.98%.

Return on Equity (ROE)	34.50%
Return on Assets (ROA)	8.89%
Return on Invested Capital (ROIC)	33.98%
Return on Capital Employed (ROCE)	21.72%
Weighted Average Cost of Capital (WACC)	12.09%
Revenue Per Employee	2.32M
Profits Per Employee	416,863
Employee Count	11,100
Asset Turnover	0.73
Inventory Turnover	3.18

Taxes

In the past 12 months, DexCom has paid 1.39 billion in taxes.

Income Tax	1.39B
Effective Tax Rate	23.16%

Stock Price Statistics

The stock price has decreased by -24.16% in the last 52 weeks. The beta is 1.56, so DexCom's price volatility has been higher than the market average.

Beta (5Y)	1.56
52-Week Price Change	-24.16%
50-Day Moving Average	6.88
200-Day Moving Average	7.67
Relative Strength Index (RSI)	36.25
Average Volume (20 Days)	1,867

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.44

Income Statement

In the last 12 months, DexCom had revenue of BRL 25.68 billion and earned 4.61 billion in profits. Earnings per share was 11.51.

Revenue	25.68B
Gross Profit	15.43B
Operating Income	5.02B
Pretax Income	5.99B
Net Income	4.61B
EBITDA	6.41B
EBIT	5.02B
Earnings Per Share (EPS)	11.51

Balance Sheet

The company has 11.01 billion in cash and 7.69 billion in debt, giving a net cash position of 3.32 billion.

Cash & Cash Equivalents	11.01B
Total Debt	7.69B
Net Cash	3.32B
Net Cash Per Share	n/a
Equity (Book Value)	15.12B
Book Value Per Share	39.31
Working Capital	10.41B

Cash Flow

In the last 12 months, operating cash flow was 7.94 billion and capital expenditures -2.00 billion, giving a free cash flow of 5.93 billion.

Operating Cash Flow	7.94B
Capital Expenditures	-2.00B
Depreciation & Amortization	1.25B
Net Borrowing	-6.02B
Free Cash Flow	5.93B
FCF Per Share	n/a

Margins

Gross margin is 60.10%, with operating and profit margins of 19.56% and 17.94%.

Gross Margin	60.10%
Operating Margin	19.56%
Pretax Margin	23.35%
Profit Margin	17.94%
EBITDA Margin	24.96%
EBIT Margin	19.56%
FCF Margin	23.11%

Dividends & Yields

DexCom does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.75%
Shareholder Yield	1.75%
Earnings Yield	3.91%
FCF Yield	5.03%

Stock Splits

The last stock split was on June 13, 2022. It was a forward split with a ratio of 4.

Last Split Date	Jun 13, 2022
Split Type	Forward
Split Ratio	4

Scores

DexCom has an Altman Z-Score of 7.06 and a Piotroski F-Score of 6.

Altman Z-Score	7.06
Piotroski F-Score	6